Magellan Diagnostics (Meridian Bioscience, Inc., NASDAQ: VIVO) Signs Exclusive Partnership to Expand Blood Lead Testing in China
CINCINNATI, Dec. 20, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that its Magellan Diagnostics business unit has signed an exclusive distribution agreement with MedCaptain Medical Technology Co., Ltd. (MedCaptain, www. …